121 INTERIM SAFETY-ANALYSIS OF THE AVATACE-1 TRIAL (BEVACIZUMAB AS INHIBITOR OF COLLATERAL TUMOR-VESSEL-GROWTH DURING TRANSARTERIAL CHEMOEMBOLISATION (TACE) FOR HEPATOCELLULAR CARCINOMA – A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED PILOT-TRIAL | Publicación